B ZAHOROWSKA1, K ISMAIL2, G NARAYANAN1 1Liverpool Hospital, Liverpool, New South Wales; 2Department of Anatomical Pathology, Liverpool Hospital, Liverpool, New South Wales Background: Gastrointestinal mucormycosis is a rare opportunistic infection predominately affecting individuals with immune deficiency and predisposing conditions including gastric...
- 9 August 2017
B ZAHOROWSKA1, I DE GUZMAN1, B CLELAND1, A ARAVINDAN1, J WONG1 1Liverpool Hospital, Liverpool, New South Wales Background: Peritoneal dialysis (PD) catheter insertion can be performed by percutaneous Seldinger technique with ultrasound guidance and image intensification to confirm intraperitoneal positioning....
- 9 August 2017
E TAN1, S GODDARD1 1Regional Renal Unit, Waikato Hospital, Hamilton, New Zealand Aim: To describe a case series of Peritoneal Dialysis Catheter (PDC) Insertions (PDCI)s for recurrent Ascites Drainage (AD) Background: Interventional nephrologists insert 60 PDCs annually (50%) in Waikato...
- 9 August 2017
K HAWKE1, I ISMAIL1, A LEE1, M FAHIM2, A GUPTA1 1Department of Nephrology, Toowoomba Hospital, Queensland; 2Department of Nephrology, Princess Alexandra Hospital, Queensland Aim: We present a lung transplant patient with a diagnosis of sepsis secondary to M morganii PD peritonitis,...
- 9 August 2017
V KHELGI1, 2 A GUPTA1, 2, 1Renal unit, Toowoomba Hospital, Toowoomba, Queensland; 2Rural School of Medicine, University of Queensland Toowoomba, Queensland Background: Chylous ascitis (CA) in peritoneal dialysis (PD) patients is a very rare complication. Due to its milky appearance, it can...
- 9 August 2017
E YII4*, JCG DOERY3,4, Z KAPLAN2,4, PG KERR1,4. 1Department of Nephrology, 2Haematology; 3Pathology – Monash Health; 4Department of Medicine, Monash University, Clayton, Victoria. (* medical student). Aim: To determine the efficay and safety of desferasirox in PD patients. Background: A 54 year...
- 9 August 2017
S CROCKER1 1John Hunter Hospital, Newcastle, New South Wales Background: Peritoneal dialysis (PD) continues to remain a viable dialysis modality with at least 60-90% of home-based patients performing PD across Australia. PD allows patients to maintain greater independence and a more...
- 9 August 2017
K MULRONEY1, T INGLIS2, A CHAKERA1, 3, 1Translational Renal Research Group, Harry Perkins Institute of Medical Research, Perth, Western Australia; 2Department of Microbiology, PathWest Laboratory Medicine, Perth, Australia; 3Renal Unit, Sir Charles Gairdner Hospital, Perth, Western Australia Aim: To use flow cytometry...
- 9 August 2017
D FORTNUM1, N HAWKINS2, G VANDEPEER3, A CHAKERA1,4 1Translational Renal Research Group, Harry Perkins Institute of Medical Research, Perth, Western Australia; 2Hospital in the Home, Sir Charles Gairdner Hospital, Perth, Western Australia; 3Fresenius Medical Care, Perth, Australia; 4Renal Unit, Sir Charles Gairdner Hospital,...
- 9 August 2017
K MULRONEY1, J HALL2, T INGLIS2, A CHAKERA1, 3, 1 Translational Renal Research Group, Harry Perkins Institute of Medical Research, Perth, Western Australia; 2Department of Microbiology, PathWest Laboratory Medicine, Perth, Australia; 3Renal Unit, Sir Charles Gairdner Hospital, Perth, Western Australia Aim: To...
- 9 August 2017